The Prevalence of Alzheimer’s disease, Glaucoma and Age-related Macular Degeneration
About the Research Project
Program
Award Type
Other
Award Amount
$4,000
Active Dates
January 01, 2013 - October 11, 2013
Grant ID
CA2013001
Summary
The purpose of this report is to consolidate information on the individual and joint prevalence of Alzheimer’s disease, age-related macular degeneration (AMD) and glaucoma. In this report, the most current and robust sources for prevalence of each condition are identified and the joint prevalence of each combination of disease is calculated. While correlation of risk is likely to exist among these diseases, currently available evidence does not support the estimation of any such correlation. Thus, the prevalence results in this report are based on an assumption of independence of risk for each disease. This produces a conservative estimation of the prevalent population suffering from more than one disease. This report can serve as a guide to illustrate the probable prevalence of each of the three diseases and combinations of each in the US population by age. We calculated the prevalent population with each disease based on reported prevalence rates by age, and population by age identified in the 2010 US census. The following results are based on the latest evidence in the literature on the prevalence of each disease, as measured through gold-standard diagnosis criteria in community settings. Thus, these represent the true prevalence rate, including undiagnosed cases.
Grants
Related Grants
Alzheimer's Disease Research
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Alzheimer's Disease Research
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Gael Chetelat, PhD
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Gael Chetelat, PhD
Alzheimer's Disease Research
Mitochondrial Prodrug to Treat Repeated Mild Traumatic Brain Injury
Active Dates
September 08, 2021 - December 31, 2023
Principal Investigator
Patrick Sullivan, PhD
Mitochondrial Prodrug to Treat Repeated Mild Traumatic Brain Injury
Active Dates
September 08, 2021 - December 31, 2023
Principal Investigator
Patrick Sullivan, PhD